Trial Profile
Safety of Dabigatran in Patients Undergoing an Invasive Procedure.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Blood coagulation disorders
- Focus Adverse reactions
- 01 Jul 2014 New trial record